Moderna MRNA Ratios (2017-2026)

NASDAQ MRNA
$145.53 -3.34 (-2.24%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Moderna Quarterly Ratios

Periods 35 quarters
Latest Jun 2026

Moderna reported a gross margin of 35.86% and a net margin of -539.31% for the quarter ended Jun 2026. These financial ratios cover 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
85.47%86.80%83.23%70.92%67.30%92.13%57.47%-112.50%-22.39%66.95%42.51%52.28%72.40%23.50%16.67%16.20%79.63%33.33%-145.50%35.86%
EBT Margin
71.48%75.02%69.72%52.10%36.18%32.55%-16.38%-508.43%-106.94%2.49%-697.60%-530.71%1.13%-122.57%-892.59%-576.06%-18.41%-117.85%-342.93%-528.97%
EBIT Margin
71.60%75.02%69.68%51.53%34.66%31.08%-19.66%-542.73%-109.89%0.21%-758.08%-565.56%-3.76%-128.99%-972.22%-638.73%-25.59%-126.40%-356.81%-562.07%
EBITDA Margin
71.60%75.02%69.68%51.53%34.66%31.08%-19.66%-542.73%-109.89%0.21%-758.08%-565.56%-3.76%-128.99%-972.22%-638.73%-25.59%-126.40%-356.81%-562.07%
Operating Margin
71.60%75.02%69.68%51.53%34.66%31.08%-19.66%-542.73%-109.89%0.21%-758.08%-565.56%-3.76%-128.99%-972.22%-638.73%-25.59%-126.40%-356.81%-562.07%
Net Margin
67.08%67.51%60.29%46.26%31.00%28.82%4.24%-401.16%-198.25%7.72%-703.59%-530.71%0.70%-115.94%-899.07%-580.99%-19.69%-121.83%-345.24%-539.31%
FCF Margin
63.94%44.24%43.37%4.57%4.85%30.88%-71.86%-334.01%-95.03%14.30%-709.58%-604.15%-92.21%31.37%-1,068.52%-649.30%-86.61%131.42%-177.89%-388.28%
Efficiency
Inventory AverageInventory Avg.
0.80B1.20B1.69B1.93B2.00B1.51B0.84B0.72B0.60B0.34B0.25B0.35B0.41B0.26B0.12B0.18B0.29B0.24B0.15B0.21B
Assets AverageAssets Avg.
18.54B22.80B26.14B26.83B26.05B25.96B24.99B23.00B20.67B18.94B17.58B16.20B15.74B14.97B13.42B12.36B12.07B12.24B11.91B11.22B
Invested CapitalInvested Cap.
10.90B9.24B8.00B7.35B
Asset Utilization RatioAsset Util.
0.640.810.860.860.820.740.600.460.440.360.290.310.320.220.240.250.180.160.190.20
Leverage & Solvency
Debt Ratio
0.050.050.05
Valuation
Price to EarningsP/E
46.7721.0318.8425.4943.8847.20746.52-33.54-10.84175.07-34.73-35.650.00B-14.33-11.30-13.01-50.50-14.07-15.02-35.73
Price to SalesP/S
31.3714.1911.3611.7913.6013.6031.67134.5721.4913.51244.39189.2113.8216.61101.5975.589.9417.1451.84192.70
Price to BookP/B
15.407.244.043.112.543.623.132.732.922.743.183.892.161.471.091.141.081.342.724.13
Enterprise Value
146.96B91.63B58.79B48.10B37.41B59.25B50.05B37.83B31.78B29.39B32.29B37.11B18.86B9.02B5.00B5.60B5.60B5.82B14.96B22.80B
EV to EBIT
41.3016.9413.9119.6632.0937.50-136.75-20.26-15.800.00B-25.51-27.23-269.47-7.24-4.76-6.18-21.52-6.79-10.78-27.98
EV to EBITDA
41.3016.9413.9119.6632.0937.50-136.75-20.26-15.800.00B-25.51-27.23-269.47-7.24-4.76-6.18-21.52-6.79-10.78-27.98
Market Capitalization
155.87B102.35B68.90B56.00B45.76B69.15B58.97B46.29B39.35B37.99B40.81B45.60B25.73B16.05B10.97B10.73B10.10B11.62B20.17B27.94B
Price to FCFP/FCF
49.0632.0926.19258.05280.7544.05-44.08-40.29-22.6294.50-34.44-31.32-14.9952.97-9.51-11.64-11.4813.04-29.14-49.63
EV to FCF
46.2628.7222.34221.66229.5437.74-37.41-32.93-18.2673.10-27.25-25.49-10.9929.79-4.33-6.08-6.366.53-21.62-40.50
EV to CFO
44.8627.6821.28158.22148.4735.65-40.86-41.35-19.8647.24-32.65-29.13-12.0510.94-4.82-6.10-6.616.26-23.75-43.35
Return Ratios
Return on Sales [ROS]ROS
71.60%75.02%69.68%51.53%34.66%31.08%-19.66%-542.73%-109.89%0.21%-758.08%-565.56%-3.76%-128.99%-972.22%-638.73%-25.59%-126.40%-356.81%-562.07%
Return on Capital Employed [ROCE]ROCE
88.70%97.28%96.19%78.16%68.86%44.78%22.46%2.58%-16.37%-26.62%-33.81%-33.49%-19.89%-30.90%-31.55%-30.35%-33.33%-29.99%-35.85%-38.20%
Return on Invested Capital [ROIC]ROIC
-40.29%-44.15%
Return on Assets [ROA]ROA
38.09%53.53%56.00%52.39%45.16%32.21%19.14%5.25%-16.77%-24.89%-33.95%-36.21%-14.13%-23.78%-25.01%-23.49%-25.81%-23.06%-26.81%-28.07%